G. Traversa

21 papers receiving 391 citations

Peers

G. Traversa
Comparison fields: 5 of 91
  • Pharmacology 87
  • Applied Microbiology and Biotechnology 19
  • Pharmacology 143
  • Toxicology 15
  • Health 31
Replace Xianmei Zhou with:
Xianmei Zhou China
E. Pérez Spain
Hoan Linh Banh Canada
David F. Lehmann United States
JEFF EVANS United Kingdom
Dawn Harper United States
Marcel de Wilde Netherlands
Ippazio Cosimo Antonazzo Italy
Janelle F. Ruisinger United States
Adrienne Smith United States
G. Traversa relative to Xianmei Zhou China Xianmei Zhou's profile →
Citations per field
00.5×4.4×
Xianmei Zhou · 1×
Citations per year

Countries citing papers authored by G. Traversa

Since Specialization
Citations

This map shows the geographic impact of G. Traversa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Traversa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Traversa more than expected).

Fields of papers citing papers by G. Traversa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Traversa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Traversa. The network helps show where G. Traversa may publish in the future.

Co-authors

The 25 scholars most cited alongside G. Traversa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Traversa Line = papers co-authored together G. Traversa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003138
2 199582
3 201436
4 200432
5 199830
6 199525
7
Retrospective comparison of long-term ten-day/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis.
201715
8
Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.
199911
9 199310
10 199510
11
[Sedation with propofol in endoscopic retrograde cholangiopancreatography: personal experience].
20085
12 19905
13
Extrapyramidal reactions in children treated with metoclopramide
20044
14 20133
15 19982
16 19962
17 20132
18 20051
19 19961
20
[Ethics problems in phase IV of drug studies].
19981

About G. Traversa

G. Traversa is a scholar working on Applied Microbiology and Biotechnology, Health, Pharmacology, Pharmacy and Psychiatry and Mental health, having authored 23 papers that have together received 417 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (3 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers), Vaccine Coverage and Hesitancy (2 papers), Healthcare Systems and Technology (2 papers), Inflammatory mediators and NSAID effects (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Pharmaceutical Economics and Policy (2 papers) and Gallbladder and Bile Duct Disorders (2 papers). The work is most often cited by research in Pharmacology (87 citations), Applied Microbiology and Biotechnology (19 citations), Pharmacology (143 citations), Toxicology (15 citations) and Health (31 citations). G. Traversa has collaborated with scholars based in Italy, United States and Armenia. Frequent co-authors include Stefania Spila Alegiani, Roberto Raschetti, Francesca Menniti‐Ippolito, Roberto Da, Angelo Dezi, M. Koch, Lucio Capurso, Marina Maggini, Delia Boccia and Maria Luisa Moro. Their work appears in journals such as European Journal of Clinical Pharmacology, Acta Psychiatrica Scandinavica, BMJ, Alimentary Pharmacology & Therapeutics and Journal of Child and Adolescent Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026